(Q33871364)

29 July 2017

Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria (English)

1 reference

seasonal allergic rhinitis

29 July 2017

1 reference

1 reference

1 reference

K Simpson

1

1 reference

PubMed ID

10730552

29 July 2017

B Jarvis

series ordinal

2

1 reference

29 July 2017

1 February 2000

1 reference

29 July 2017

1 reference

29 July 2017

59

1 reference

29 July 2017

2

1 reference

29 July 2017

301-321

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059020-00020

29 July 2017

0 references

cites work

ABC of allergies. Pathogenic mechanisms: a rational basis for treatment

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059020-00020

Clinical pharmacology of new histamine H1 receptor antagonists

21 January 2018

1 reference

12 December 2020

Mechanism of the cardiotoxic actions of terfenadine

1 reference

12 December 2020

The validity and reproducibility of a work productivity and activity impairment instrument

1 reference

12 December 2020

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

1 reference

12 December 2020

Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines

1 reference

12 December 2020

Therapeutic advantages of third generation antihistamines

1 reference

12 December 2020

Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers

1 reference

12 December 2020

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

1 reference

12 December 2020

Effect of food on the bioavailability of fexofenadine hydrochloride (MDL 16455A).

1 reference

12 December 2020

The clinical pharmacology of fexofenadine in children

1 reference

12 December 2020

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

1 reference

12 December 2020

Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis

1 reference

12 December 2020

Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.

1 reference

12 December 2020

Cardiovascular safety of fexofenadine HCl.

1 reference

12 December 2020

The systemic safety of fexofenadine HCl.

1 reference

12 December 2020

A comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus placebo in suppressing the cutaneous response to histamine

1 reference

12 December 2020

Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit

1 reference

12 December 2020

Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen

1 reference

12 December 2020

Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies

1 reference

12 December 2020

Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.

1 reference

12 December 2020

Evaluation and management of allergic rhinitis.

1 reference

12 December 2020

1 reference

12 December 2020

Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.

1 reference

12 December 2020

Urticaria and angioedema: pathophysiology, diagnosis, and treatment

1 reference

12 December 2020

QT lengthening and life-threatening arrhythmias associated with fexofenadine

1 reference

12 December 2020

Treatment options for the child with allergic rhinitis

1 reference

12 December 2020

Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines.

1 reference

12 December 2020

A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function

1 reference

12 December 2020

Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart

1 reference

12 December 2020

Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis

1 reference

12 December 2020

Peripheral H1-blockade effect of fexofenadine

1 reference

12 December 2020

Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria

1 reference

12 December 2020

Non-sedating antihistamines and cardiac arrhythmia

1 reference

12 December 2020

Effects of H1 antihistamines on adhesion molecules: a possible rationale for long-term treatment

1 reference

12 December 2020

Long QT syndromes and torsade de pointes

1 reference

12 December 2020

The impact of allergic rhinitis on quality of life and other airway diseases. Summary of a European conference

1 reference

12 December 2020

Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.

1 reference

12 December 2020

Economic outcomes for the treatment of allergic rhinitis

1 reference

12 December 2020

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

1 reference

12 December 2020

Antihistamines and aircrew: usefulness of fexofenadine.

1 reference

12 December 2020

Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects

1 reference

12 December 2020

Chronic urticaria: pathophysiology and treatment approaches.

1 reference

12 December 2020

Use of nasal steroids in managing allergic rhinitis

1 reference

12 December 2020

Cardiovascular safety of fexofenadine HCl

1 reference

12 December 2020

Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers

1 reference

12 December 2020

The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis

1 reference

12 December 2020

10.2165/00003495-200059020-00020

Identifiers

DOI

1 reference

PubMed ID

10730552

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10730552